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X-ray diffraction analysis of urinary tract stones
Turgut YAPANOĞLU1, Azam DEMİREL1, Şenol ADANUR1, Hikmet YÜKSEL2, Özkan POLAT1

Aim: To analyze urinary tract stones obtained in our clinic using various methods and to determine the spectrum of stone
composition in the Eastern Anatolia Region, Turkey.
Materials and methods: A total of 300 stones were obtained at Atatürk University, Faculty of Medicine Urology Clinic
through open surgery, percutaneous nephrolithotomy (PNL), ureterorenoscopy (URS), and extracorporeal shock-wave
lithotripsy (ESWL) between 1 January 2005 and 30 December 2008. Stones were analyzed in the laboratory of Ankara
General Directorate of Mineral Research Exploration using X-ray diffraction (XRD).
Results: It was found that 218 (72.7%) of the 300 stones were calcium oxalate (CaOx); 170 (56.7%) of which were calcium
oxalate monohydrate (COM), 12 (4%) were calcium oxalate dehydrate (COD), and 36 (12%) were COM and COD
combined stones; 23 (7.7%) were uric acid (UA), 6 (2%) were magnesium ammonium phosphate (MAP), 3 (1%) were
dahllite (DAH/hydroxyl apatite), 2 (0.6%) were cystine (CYS) stones, and 34 (11.3%) were a combination of UA and
COM stones. The remaining 14 (4.7%) stones were a combination of other stones.
Conclusion: The stone analysis study was carried out using the XRD method on 300 samples in the Eastern Anatolia
Region, where the prevalence of urinary tract stones is relatively high. The analysis showed that 72.7% of all stones were
CaOx stone and 56.7% were pure COM stones.
Key words: Urinary tract stones, x-ray diffraction, stone analysis

Üriner sistem taşlarını X-ray diffraction ile analizi
Amaç: Bu çalışmada, kliniğimizde çeşitli yöntemlerle elde edilen üriner sistem taşlarını analiz ederek, Türkiye’nin Doğu
Anadolu bölgesinin taş bileşim spekturumunu ortaya koymayı amaçladık.
Yöntem ve gereç: Atatürk Üniversitesi Tıp Fakültesi Üroloji Kliniğinde 1 Ocak 2005 ile 30 Aralık 2008 tarihleri arasında;
açık cerrahi, perkütan nefrolitotomi (PNL), üreterorenoskopi (URS) ve ekstrakorporeal şok dalga litotripsi (ESWL) ile
elde edilen total 300 taş değerlendirildi. Taşlar, Ankara Maden Tetkik ve Arama Genel Müdürlüğünde X-ray diffraction
(XRD) yöntemi ile analiz edildi.
Bulgular: Analiz edilen 300 taşın; 218’i (% 72, 7) kalsiyum oksalat (CaOx) taşı idi. CaOx taşlarının 170’i (% 56,7) kalsiyum
oksalat monohidrat (COM), 12’si (% 4) kalsiyum oksalat dihidrat (COD) ve 36’sı (% 12) COM ve COD taş bileşimi idi.
Analiz edilen taşlardan 23’ü (% 7,7) ürik asit (UA), 6’sı (% 2) magnezyum amonyum fosfat (MAP), 3’ü (% 1) dahllite
(DAH/hidroksi apatit) ve 2’si (% 0,6) sistin (CYS) taşı idi. Otuz dört (% 11,3) taş UA ve COM bileşim taşı idi. Geri kalan
14 (% 4,7) taş, diğer bileşimlerden oluşmaktaydı.
Sonuç: Bu taş analiz çalışmasında, nispeten üriner sistem taş hastalığı prevalansı yüksek olan Doğu Anadolu Bölgesinde
elde edilen 300 taş XRD ile analiz edildi. Analiz sonucu, taşların % 72,7’sının CaOx taşı ve % 56,7’sının pür COM taşı
olduğu anlaşıldı.
Anahtar sözcükler: Üriner sistem taşı, X-ray diffraksiyon, taş analizi
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Introduction
Urinary tract stone disease has been affecting
humans for centuries, and it affects a quarter of the
population in certain geographical regions and
therefore cause important health problems. Many
hereditary, nutritional, geographical, and infective
etiologic factors may cause stone formation (1). While
the risk of life-long urolithiasis in the western world is
10%-15%, this rate is 20%-25% in the Middle East (2).
Without preventative treatment, the rate of recurrence
is approximately 10.5% in 1 year, 33% in 5 years, and
50% in 10 years (3). Due to the high rate of
recurrence, analysis of the obtained stones for the
purpose of learning stone composition and
preventing future intrusive procedures is of great
importance. In stone analysis, XRD and infrared
spectroscopy (IRS) are standard methods (4,5).
Chemical methods are not reliable in stone analysis
(5).
In the Eastern Anatolia Region, stone analysis can
only be carried out by chemical methods. Since results
obtained via this method are not reliable, it was
necessary to change the method. For this reason,
starting from 2005, we began to send the stones we
obtained to the General Directorate of Mineral
Research Exploration laboratory in Ankara for XRD
analysis.
This study includes results of the first analysis we
carried out using the XRD method.
Materials and methods
Urinary tract stones, which were obtained at
Atatürk University, Faculty of Medicine Urology
Clinic between 1 January 2005 and 30 December
2008, were analyzed in the laboratory of the General
Directorate of Mineral Research Exploration in
Ankara using the XRD method. The period between
the collection and analysis of the stones varied
between 3 weeks and 3 months. The stones were
stored in a plastic bag without using any solution
between removal and XRD-analysis. A total of 300
stones were analyzed; 120 of these stones were renal
stones, 128 were ureteral stones, and 52 were bladder
stones. One hundred of the stones were obtained with
open surgery (pyelolithotomy, ureterolithotomy, or
cystolithotomy), 154 were obtained with endoscopic
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(PNL or URS) methods, and 46 were obtained by
collection of stone fragments after ESWL. Although
the number of patients who were treated with the
ESWL method was quite high, since a sufficient
amount of stone fragments could not be collected for
detections, only the stones of 46 patients were
obtained with this method.
The stones that were taken to the laboratory were
pulverized and placed into glass sample cups. Samples
were then placed into a Philips x-ray diffractometer
with a nickel filter. Mineral determination was made
from the diffraction patterns using the comparative
Hanawalt method.
Results
In this study the number of adult males (m) was
201, the number of adult females (f) was 81, m/f ratio
was 2.48, and the average age was 53 (range: 15-83).
The number of child patients (<15 years of age) was
18. Ten of these were girls and 8 were boys. In this
study, when COM, COD, UA, MAP, DAH, and CYS
stones are considered as single crystalline components
and pure stones, the pure stone rate was 72% (n = 216)
and the rate of combined stones, including the
components of these stones and others, was 28% (n =
84). Almost all (81/84) of the stone combinations
contained COM crystal. As a result, the COM
component was pure in 170 stones and a combination
in 81 stones. The proportional expression of this is
83.6%.
Out of 300 stones obtained, 170 (56.7%) were
found to be COM, 12 (4%) were COD, and 36 (12%)
were COM+COD combination. Besides, 72.7% (n =
218) of all stones were CaOx stones. There were 34
(11.3%) COM+UA combinations, 23 UA (7.7%), 6
MAP (2%), 3 DAH (1%), and 2 CYS (0.6%) stones.
The remaining 14 stones were a combination stones
that were composed of 2 or more crystalline
components.
In this study, only 3 DAH stones were detected to
be pure calcium phosphate (CaP) stone and only 2
combined stones contained brushite crystal.
In this study there were only 6 pure infection
stones (MAP), of which 5 (83.3%) were obtained from
female patients. It was a significant finding that only
2 (0.6%) of 300 stones were CYS stones (Table 1).
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When renal (n = 120) and ureteral (n = 128) stones
were further analyzed as upper urinary tract (UUT)
stones, it was found that 248 (82.6%) of the analyzed
stones were UUT stones.
One hundred and ninety five (78.63%) of UUT
stones were CaOx stones. The second most common
stone type amongst upper urinary tract stones was the
combined stone group that was composed of COM
and UA components (Table 2).
It was found that 23 (44.23%) of 52 bladder stones
were CaOx stone. UA stones ranked second among
bladder stones. The rate of pure UA stones in the
bladder was 26.92% and the total rate of bladder
stones containing UA crystalline component was 46%.
In addition, it was interesting that 60.8% (14/23) of
pure UA stones were in the bladder (Table 3).
Of the 18 stones obtained from the patients in the
pediatric age group, 13 were COM, 2 were
COM+COD, 2 were COM+UA, and 1 was CYS stone.
It was found that the stones in children were mainly
(83.33%) CaOx stone.
Table 1. Stone types and rates (all stones).
Stone Type

Number (n)

Rate (%)

CaOx
COM
170
COD
12
COM+COD
36
UA
MAP
DAH
CYS
COM+UA
OTHER COMBINED

218

23
6
3
2
34
14

72.7
56.7
4
12
7.7
2
1
0.6
11.3
4.7

TOTAL

300

100%

CaOx: calcium oxalate, COM: calcium oxalate monohydrate,
COD: calcium oxalate dehydrate, UA: uric acid, MAP:
magnesium ammonium phosphate (struvite), DAH: dahllite, CYS:
cystine.

Discussion
Medical treatments of stone disease should be
based on the analysis of the stone. The composition
of the stone should be known in order to make
accurate decisions about the treatment procedure and

Table 2. Distribution and rates of upper urinary tract stones.
Stone Type

Number (n)

Rate (%)

CaOx
COM
157
COD
10
COM+COD
28
UA
MAP
DAH
CYS
COM+UA
OTHER COMBINED

195

78.63

9
6
2
2
24
10

3.63
2.42
0.81
0.81
9.67
4.03

TOTAL

248

100%

CaOx: calcium oxalate, COM: calcium oxalate monohydrate,
COD: calcium oxalate dehydrate, UA: uric acid, MAP:
magnesium ammonium phosphate (struvite), DAH: dahllite, CYS:
cystine.
Table 3. Distribution and rates of bladder stones.
Stone Type

Number

Rate (%)

CaOx
COM
13
COD
2
COM+COD
8
UA
MAP
DAH
CYS
COM+UA
OTHER COMBINED

23

44.23

14
1
10
4

26.92
1.92
19.23
7.7

TOTAL

52

100%

CaOx: calcium oxalate, COM: calcium oxalate monohydrate,
COD: calcium oxalate dehydrate, UA: uric acid, MAP:
magnesium ammonium phosphate (struvite), DAH: dahllite, CYS:
cystine.

to prevent recurrence (6-8). Due to the high error rate
of chemical methods, for the analysis of urinary
stones, physical methods, such as XRD and IRS, are
recommended (9).
The crystal structure of urinary stones allows for
XRD analysis and is accepted as the gold standard
(10-14). This analysis is highly reliable due to its
success in the definition of chemical structures
composing the stone. The fact that this analysis can
be applied to very small samples is another advantage
417
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of the technique (9). In quality control analyses of 44
studies between 1980 and 2001, the XRD method
produced the most accurate results for determining
other components in combined stones. In this study it
was found that the error in the detection of COM
stones, which is the most common stone type in the
urinary system, using the XRD method was only 13%
(15). In recent years several publications have
discussed the utilization of XRD and x-ray coherent
scatter in the determination of the stone structure
prior to surgery and in the analysis of the whole stone
(4,14,16).
Because of the facts that different methods are
used in stone analysis and sample numbers are highly
variable, and because studies include upper urinary
tract stones or all stones, it is difficult to accurately
compare the reported results. However, many studies
have reported a common finding that CaOx stones
rank the first. On the other hand, when the existing
literature on urinary tract stone diseases is reviewed,
it is found that, depending on different regions and
the etiologic factors related with stone formation,
different stone structures emerged across the world
(17). In various studies carried out in Western Europe
and in the United States of America (18-22), it is
observed that CaOx stones make up 50%-70% of all
stones; and in studies carried out in India, located in
the Middle of Far East (17,23,24), this rate exceeds
95%. Ahlawat et al. (24) reported that CaOx
(COM/COD) stones, which were determined using
XRD analysis of 435 urinary tract stones, made up
97% of all stones in Northern India. When our study
is considered from this perspective, 72.7% of all
stones, 78.63% of the upper urinary tract stones, and
44.23% of the bladder stones were CaOx stones. The
results we obtained indicate that the distribution of
stones in our region is similar to that observed in
western societies. In a study that was carried out in
Turkey using chemical analysis, it was reported that
55% of the stones were CaOx stones (25).
CaOx stones are composed of COM and COD
crystals. COM is the most resistant structure in terms
of thermodynamics, and is more common (>2:1) than
COD in clinical stones (1,16,17,21). In our study the
ratio of COM to COD was found to be 12. This ratio
is quite high when compared to other findings
reported in the literature. In the study by Herring (19),
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the ratio of COD stones were higher than that of
COM (40.9% vs. 31.4%). In our study, CaOx stones
were categorized as COM, COD, and COM+COD.
Ansari et al. (17) considered COM+COD stones
separately from CaOx stones among other combined
stones.
In many studies, the prevalence rate of pure CaP
stones varies significantly between 6.2% and 28.9%
(19-21,25). In our study the prevalence of CaP stones
was low. As pure CaP stone, only 2 DAH (hydroxyl
apatite) stones were found, and in 2 combined stones,
brushite crystal was found. Similarly, there were only
2 stones in which CaOx and CaP stones were
combined. This inconsistency with other studies
mentioned above can be explained by the lower
number of analyzed stone samples.
The prevalence of UA stones varies between 4.5%
and 23%. More than 15% of urinary stones in Taiwan,
Korea, and Saudi Arabia are comprised of UA stones
(28). Ansari et al. (17) found that the rate of UA stones
was only 0.95%. In our study, pure UA stones made
up 7.7% of all stones; 3.63% of the UUT stones, and
26.92% of the bladder stones. In addition, when we
consider COM and combined UA stones, 19%
(57/300) of all stones contained UA. Our findings are
generally consistent with other studies except that
bladder stones in our study included a higher rate of
UA stones (26.92%). Among urinary stones, the rate
of MAP stones was reported to be between 9.3% and
21.5% in various studies (11,18,19,21,26). Ansari et al.
reported 1.42% MAP stone rate (17). In our study, the
rate of pure MAP stones was only 2% (6/300). In
addition, one combined stone had a MAP component.
This indicates that in our study the number of MAP
stones is low, which is similar to the findings of Ansari
et al. (17). On the other hand, the fact that almost all
of the MAP stones are observed in women due to
their tendency to infection is an expected result. Gault
and Chafe (26) emphasized that 54% of MAP stones
were observed in women.
CYS stones are rarely observed urinary tract
stones. Prien and Frondel (11) reported that the
prevalence of CYS stones was 3.8%. In many other
studies (19,20,21,22,26) the prevalence of CYS stones
is 1% or lower. Ansari et al. (17) did not detect any
CYS stone among 1050 stones they analyzed using the
XRD method. In our study only 2 (0.6%) pure CYS
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stones were found. In previous studies carried out in
our clinic, no CYS stones were detected (29,30). This
indicates that CYS stones are rare in our region.
Different results were reported in previous studies
of bladder stone analysis. In the study by Otnes (21),
in which he analyzed 100 bladder stones using the
XRD method, a mix stone composed of CaOx and
CaP ranked first with a rate of 34%, and CaOx stones
ranked fourth with a rate of 15%. Gault and Chafe
(26) analyzed 1067 bladder stones and reported that
CaOx stones ranked first with a rate of 65%. In that
study it was interesting that the rate of bladder stones
containing MAP stones was found to be 20%. In our
study 44.23% (23/52) of the analyzed bladder stones
were CaOx stones. The rate of pure UA stones in the
bladder was 26.92% (14/52) and the total rate of
bladder stones containing UA stone was 46.15%. Only
one combined bladder stone contained a MAP
component. In terms of the high rate of UA stones and
low rate of MAP stones, the findings of our analyses
regarding bladder stones appear to be inconsistent
with the above mentioned studies.
It is known that in many regions of the world,
childhood stone diseases are endemic. Studies
indicate that childhood stone diseases are related to

nutritional disorders and the majority of the stones
are mix stones composed of ammonium acid urate,
CaOx, or a mixture of them (31-33). In our study the
number of child patients was limited. However, the
fact that 18 stones obtained from the patients in the
pediatric age group did not contain ammonium acid
urate and the majority of these stones (83.33%)
contained only CaOx is inconsistent with the previous
findings.
Conclusion
Currently advanced techniques can be used in the
treatment of urinary tract stones. However, for the
prevention of recurrence, stone analyses are still
important.
In the present study, which analyzed 300 stones
using the XRD method, it was found that 72.7% of all
stones were CaOx stones and 56.7% were pure COM
stones. When the results we obtained are compared
with the data from the published literature, it is found
that the prevalence of CaP and MAP stones is lower in
our sample. However, for the complete specification of
stone profile in our region, studies with larger samples
should be carried out.
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